financetom
Business
financetom
/
Business
/
Zebra Technologies Q3 sales edge past estimates on lower-than-expected tariff impact
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Zebra Technologies Q3 sales edge past estimates on lower-than-expected tariff impact
Oct 28, 2025 3:52 AM

Overview

* Zebra Q3 net sales rise 5.2% yr/yr, beating analyst expectations

* Adjusted EPS for Q3 beats analyst expectations, reflecting strong operational performance

* Company plans $500 mln share repurchase over next 12 months

Outlook

* Company expects Q4 sales growth between 8% and 11%

* Adjusted EBITDA margin for Q4 expected to be around 22%

* Non-GAAP EPS for Q4 expected to be $4.20 to $4.40

Result Drivers

* DEMAND AND TARIFFS - Co attributes strong Q3 results to solid demand and lower-than-expected tariffs, per CEO Bill Burns

* SEGMENT GROWTH - AIT segment sales increased 10.6% yr/yr, contributing significantly to overall sales growth

* ACQUISITION IMPACT - Recent acquisition of Elo Touch Solutions expected to accelerate connected frontline vision

Key Details

Metric Beat/Mis Actual Consensu

s s

Estimate

Q3 Sales Beat $1.32 $1.31

bln bln (13

Analysts

)

Q3 Beat $3.88 $3.75

Adjusted (14

EPS Analysts

)

Q3 EPS $1.97

Analyst Coverage

* The current average analyst rating on the shares is "buy" and the breakdown of recommendations is 12 "strong buy" or "buy", 6 "hold" and no "sell" or "strong sell"

* The average consensus recommendation for the electronic equipment & parts peer group is "buy"

* Wall Street's median 12-month price target for Zebra Technologies Corp ( ZBRA ) is $375.00, about 17.2% above its October 27 closing price of $310.57

* The stock recently traded at 18 times the next 12-month earnings vs. a P/E of 20 three months ago

Press Release:

For questions concerning the data in this report, contact [email protected]. For any other questions or feedback, contact .

(This story was created using Reuters automation and AI based on LSEG and company data. It was checked and edited by a Reuters journalist prior to publication.)

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Volkswagen recalls over 89,000 US vehicles over risk of fire, NHTSA says
Volkswagen recalls over 89,000 US vehicles over risk of fire, NHTSA says
May 26, 2025
May 10 (Reuters) - German automaker Volkswagen will recall 89,417 vehicles in the United States over an increased risk of fire due to loose cylinder head screws that might allow oil to leak, the U.S. National Highway Traffic Safety Administration (NHTSA) said on Saturday. ...
Wellness companies eager to avoid WeightWatchers' fate embrace weight-loss drugs 
Wellness companies eager to avoid WeightWatchers' fate embrace weight-loss drugs 
May 26, 2025
NEW YORK, May 10 (Reuters) - Health and wellness companies are embracing weight-loss drugs and building offerings around them in an effort to avoid the fate of WeightWatchers, which declared bankruptcy this week, citing vastly increased use of the new blockbuster medicines. But some of WeightWatchers' closest rivals, newer telehealth companies, face a new challenge of their own as federal...
Google agrees $36 million fine for anti-competitive deals with Australia telcos
Google agrees $36 million fine for anti-competitive deals with Australia telcos
Aug 17, 2025
SYDNEY, Aug 18 (Reuters) - Google agreed on Monday to pay a A$55 million ($35.8 million) fine in Australia after the consumer watchdog found it had hurt competition by paying the country's two largest telcos to pre-install its search application on Android phones, excluding rival search engines. The fine extends a bumpy period for the Alphabet-owned internet giant in Australia,...
Wellness companies eager to avoid WeightWatchers' fate embrace weight-loss drugs
Wellness companies eager to avoid WeightWatchers' fate embrace weight-loss drugs
May 26, 2025
NEW YORK (Reuters) -Health and wellness companies are embracing weight-loss drugs and building offerings around them in an effort to avoid the fate of WeightWatchers, which declared bankruptcy this week, citing vastly increased use of the new blockbuster medicines. But some of WeightWatchers' closest rivals, newer telehealth companies, face a new challenge of their own as federal regulators crack down...
Copyright 2023-2026 - www.financetom.com All Rights Reserved